Sunshine Biopharma, Inc·4/A

Oct 4, 7:03 PM ET

MERZOUKI ABDERRAZZAK 4/A

4/A · Sunshine Biopharma, Inc · Filed Oct 4, 2019

Insider Transaction Report

Form 4/AAmended
Period: 2016-12-06
MERZOUKI ABDERRAZZAK
DirectorChief Operating Officer
Transactions
  • Award

    Common Stock

    2016-12-06$0.00/sh+28,000,000$28,00038,000,000 total

Documents

1 file
  • 4
    primary_doc.xml

    PRIMARY DOCUMENT